|

$400 Million Sandoz Generic Drug Settlement, Illinois Buyers May Qualify for Compensation

Illinois consumers who bought certain generic prescription drugs may be eligible for compensation from a $400 million settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc. The deal resolves claims by a coalition of state attorneys general, including Illinois Attorney General Kwame Raoul, who accused Sandoz and other generic drug makers of price fixing, market allocation and bid rigging.

Important timing point: the settlement still needs final court approval, and the official AG Generic Drugs website lists the Sandoz claim deadline as “TBD.” The Sandoz claims process opened on September 22, 2026, so eligible Illinois consumers can register now instead of waiting.

Quick Facts: Sandoz $400 Million Multistate Settlement

Settlement DetailWhat the Official Records Show
CompaniesSandoz Inc. and Fougera Pharmaceuticals Inc.
Settlement amount$400,000,000
Payment structure$320,560,180 plus interest over seven years, totaling $400 million
Purchase periodMay 1, 2009 through December 31, 2019
Illinois statusParticipating jurisdiction
Claims process openedSeptember 22, 2026
Sandoz claim deadlineTBD
Settlement statusPending court approval
Official claim websiteAGGenericDrugs.com
Administrator phone / email1-866-290-0182 / [email protected]
CourtU.S. District Court for the District of Connecticut
Main caseState of Connecticut et al. v. Sandoz, Inc. et al., No. 3:20-cv-00802-MPS

Sandoz has said the settlement is not an admission of wrongdoing.

Why Sandoz Agreed to Pay $400 Million Over Generic Drug Prices

The settlement grows out of a large multistate antitrust case against generic drug manufacturers. The state attorneys general allege that competitors coordinated instead of competing on price, which could have made consumers pay more than they would have in a competitive market.

The allegations cover many drug categories, including antibiotics, antidepressants, contraceptives and anti-inflammatory drugs, and some drugs used for conditions such as diabetes, cancer, ADHD, epilepsy, HIV and multiple sclerosis.

These are allegations from government litigation. The settlement does not mean every allegation was proven at trial, and Sandoz has denied wrongdoing. The litigation concerns pricing and competition, not the safety or effectiveness of the medications.

Who Can Claim Under the Sandoz Settlement in Illinois?

Consumers who bought a qualifying generic prescription drug in the United States between May 1, 2009, and December 31, 2019 may be eligible, subject to residency and other requirements. You generally need to have:

  • Purchased a drug on the official covered-drug list during the purchase period.
  • Bought it in the United States for personal use, not for resale.
  • Met the residency requirements when filing your claim.

Buying the drug in Illinois is not the only test. Because eligibility turns on the drug, the dates and residency, use the official eligibility tool on AGGenericDrugs.com rather than assuming a purchase qualifies.

$400 Million Sandoz Generic Drug Settlement, Illinois Buyers May Qualify for Compensation

Sandoz Claim Deadline for Illinois Consumers: Still TBD

No Sandoz-specific claim deadline has been published. The official website says only signed, valid claims submitted by the eventual deadline will be included in the initial distribution, although late claims may be considered for later distributions.

Do not use March 8, 2027 as the Sandoz deadline. That date applies to an earlier group of settlements, including Glenmark. The same website lists the Sandoz deadline separately as TBD.

How to File a Sandoz Generic Drug Settlement Claim in Illinois

  1. Check the covered drug list. Not every generic medication qualifies. The drug must be on the official list.
  2. Confirm your purchase dates. The purchase must fall between May 1, 2009 and December 31, 2019.
  3. Confirm your Illinois residency and other requirements. Review the eligibility rules in the official claim process.
  4. Complete the claim form on AGGenericDrugs.com. Read the certification carefully before you sign and submit.
  5. Keep records. Save your confirmation, plus pharmacy receipts, insurance Explanation of Benefits statements or payment records. The administrator may ask for them later. Your pharmacy or insurer portal can often supply old purchase history.
  6. Watch for the deadline. It remains TBD as of October 2, 2026, so monitor the website and the email address you gave the administrator.

Filing a claim is free. Be careful with third-party sites that charge fees to file for you, and start from the official site or the administrator at 1-866-290-0182.

Is the Sandoz $400 Million Settlement Final?

No. It is pending court approval. Three things are happening on different timelines:

  1. The settlement agreement has been reached.
  2. The claims process has opened.
  3. Final court approval and distribution have not been completed.

Sandoz announced the agreement in August 2026 and said it was conditioned on approval by the participating states. The New York Attorney General’s October 1, 2026 announcement continued to describe the matter as requiring court approval.

How Much Money Will Illinois Claimants Receive From Sandoz?

No fixed individual payment has been announced, and the $400 million is not divided equally among claimants. Payment will depend on the approved allocation plan, the settlement funds available and the number and type of valid claims. Sandoz’s payments begin in 2027 under the announced structure.

Tax treatment of settlement payments can vary with your situation, so consider asking a tax professional if you receive a payment.

Which Court Is Handling the Sandoz Generic Drug Case?

The principal state action is State of Connecticut et al. v. Sandoz, Inc. et al., No. 3:20-cv-00802-MPS, in the U.S. District Court for the District of Connecticut. It names Connecticut and many other states and territories as plaintiffs, and Sandoz Inc., Fougera Pharmaceuticals Inc. and other drug makers among the defendants. The case began in related proceedings in the Eastern District of Pennsylvania as part of the broader generic drug antitrust litigation.

Sandoz $400 Million Settlement vs. the Sandoz $275 Million Settlement

There is a second Sandoz settlement, and readers should not mix them up. The $400 million settlement covered here is the multistate attorneys general settlement. It is not an increase of the earlier $275 million deal, which is a separate federal end-payer settlement in the multidistrict litigation. Eligibility rules, funds and claim procedures can differ.

Read our separate guide: Sandoz $275,000,000 Generic Drugs Settlement, Check If You Qualify — In re Generic Pharmaceuticals Antitrust Litigation, No. 16-MD-2724

Before you file, confirm which settlement you are claiming against and follow the instructions on its official website.

Sandoz Generic Drug Settlement Key Dates

EventDate
Generic drug state litigation began2016
Sandoz state case filed2020
Consumer purchase periodMay 1, 2009 – Dec. 31, 2019
$400 million settlement in principle announcedAug. 3, 2026
Sandoz claims process openedSept. 22, 2026
New York announced the $400 million agreementOct. 1, 2026
Sandoz claim deadlineTBD
Final court approvalPending
Sandoz payments begin2027

FAQs: Sandoz $400 Million Generic Drug Settlement in Illinois

Can Illinois consumers qualify for the Sandoz $400 million settlement?

Yes. Illinois is a participating jurisdiction, and Attorney General Kwame Raoul has urged Illinois consumers to check the list of qualifying drugs and their eligibility.

What is the Sandoz settlement claim deadline?

It is currently TBD. The claims process opened September 22, 2026, but no deadline for the initial distribution has been posted.

Can I file a Sandoz claim now?

Yes. The official AG Generic Drugs website says the Sandoz claims process is open. Use the site to check eligibility and file.

Which Sandoz generic drug purchase dates qualify?

Purchases made between May 1, 2009 and December 31, 2019, subject to the specific drug and other eligibility requirements.

Did I have to buy the drug in Illinois to claim?

Not necessarily. Eligibility depends on the covered drug, the purchase period and the residency rules. Illinois residents are included among the participating jurisdictions.

Is the Sandoz $400 million settlement approved?

Not finally. It remains subject to the required court approval process.

How much will each Sandoz claimant receive?

No individual amount has been announced. It depends on the allocation process and the number and type of valid claims.

Did Sandoz admit it fixed generic drug prices?

No. Sandoz says the settlement contains no admission of wrongdoing.

Does the Sandoz settlement mean my generic drugs were unsafe?

No. The litigation is about alleged price fixing and anticompetitive conduct, not drug safety or effectiveness.

Is the $400 million Sandoz settlement the same as the $275 million Sandoz settlement?

No. They are separate tracks: the $400 million deal is the multistate attorneys general settlement, and the $275 million deal is a separate federal end-payer settlement.

Where can Illinois consumers check the Sandoz settlement?

Use AGGenericDrugs.com, or contact the administrator at 1-866-290-0182 or [email protected].

What Illinois Consumers Should Do Now

The $400 million Sandoz settlement is real, but the final Sandoz claim deadline has not been published. If you bought a qualifying generic prescription drug between May 1, 2009 and December 31, 2019, check AGGenericDrugs.com now, keep your pharmacy, insurance or payment records, and watch for the deadline.

This article is for informational purposes only and is not legal advice.

Researched and written by Israr Ahmad, legal content researcher and founder of AllAboutLawyer.com. All facts verified against the Illinois Attorney General and New York Attorney General announcements, the official AG Generic Drugs settlement website, and the U.S. District Court for the District of Connecticut docket (No. 3:20-cv-00802-MPS), as of October 2, 2026. Last Updated: October 2, 2026.

About the Author

Israr Ahmad is a legal content researcher with 4+ years of experience covering class action settlements and consumer rights cases. He has researched and published coverage of 2,500+ settlements using verified court records, settlement administrator filings, and government sources. Learn more about Israr.

Leave a Reply

Your email address will not be published. Required fields are marked *